A groundbreaking new malaria vaccine that could be three times more effective than existing jabs is under development by ...

The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.

Australian study finds no adverse impact of repeated Covid vaccinations on metabolism, inflammation, or cardiovascular ...

AstraZeneca has warned that countries must buy more of its cutting-edge medicines or jobs and investment will shift abroad.

Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting ...

Combining multiple vaccines may trigger stronger immune responses in fewer shots, potentially improving the efficacy of ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

BioKangtai In March 2025, BioKangtai and AstraZeneca entered into a strategic partnership to establish a joint venture that focus on researching, developing, and producing innovative vaccines.

Bojan Pancevski is The Wall Street Journal’s chief European political correspondent, covering European and global affairs. He ...

Docquity, Southeast Asia's largest community of healthcare professionals (HCPs), and global biopharmaceutical leader ...